Associate Professor, Department of Clinical and Experimental Medicine, Endocrinology II Unit, University of Pisa, Pisa University Hospital; Head of the Centre for the Study and Treatment of Thyroid Eye Disease (Graves' Ophthalmopathy)
Michele Marinò was born in Martina Franca (TA) on 16/05/1965. He graduated in Medicine and Surgery in 1991 and completed his specialisation in Endocrinology and Metabolic Diseases in 1996, both at the University of Pisa. He completed his training as a Post-Doctoral Fellow at the Pathology Research Laboratory of Massachusetts General Hospital, Harvard Medical School (1997–2000), and received an American Thyroid Association Grant in 1999. From 2000 to 2003 he was a Consultant physician at Pisa University Hospital (AOUP). From 2004 (confirmed in 2007) to 2018 he was a Researcher at the Department of Clinical and Experimental Medicine, Endocrinology I Unit, University of Pisa, Pisa University Hospital. In 2014 he obtained the National Scientific Qualification for the rank of Associate Professor. Since 2018 he has been Associate Professor of Endocrinology at the Department of Clinical and Experimental Medicine, Endocrinology II Unit, University of Pisa, Pisa University Hospital.
Michele Marinò is Head of the Day Hospital (DH) and of the Outpatient Clinic for the study and treatment of Thyroid Eye Disease (Graves' Ophthalmopathy). His clinical work focuses in particular on thyroid diseases and thyroid eye disease.
His research concerns the pathogenesis and treatment of thyroid eye disease (Graves' ophthalmopathy) and the synthesis of thyroid hormones. For this work he has obtained PRIN funding from the Ministry of Universities and Scientific Research, as Unit Leader and as National Coordinator, as well as funding from the American Thyroid Association and the University of Pisa.
In addition to several book chapters, Michele Marinò is the author of numerous publications in international peer-reviewed journals, most of them as first or last author, available at the following link: click here
Michele Marinò is a member of the Executive Committee of the European Group On Graves' Orbitopathy (EUGOGO), and a member of the European Thyroid Association, the American Thyroid Association, the European Society of Endocrinology, the Italian Society of Endocrinology, the Italian Thyroid Association and the Pisa Endocrinology Alumni Association.
From 2004 to 2015 he was Coordinating Managing Editor, and from 2015 to 2018 Chief Managing Editor, of the journal “l’Endocrinologo” (Springer). He is a member of the Editorial Board of the Journal of Endocrinological Investigation and Associate Editor of Frontiers in Endocrinology. He acts as a reviewer for the main international journals in the field of endocrinology and cellular and molecular biology.
Michele Marinò teaches in the Integrated Course of Endocrinology and in the Specialisation School in Endocrinology and Metabolic Diseases of the Faculty of Medicine and Surgery, University of Pisa.
Michele Marinò also works privately in Pisa at the Endocrinology Medical Practice (Tel. 050/525556), and in Perano (CH) at the Polo Medico San Tommaso (Tel. 0872/665126 - 379/2325451).
Information / home page
michelemarino.org/home/informazioni/
In addition to 15 book chapters, he has 68 publications in international peer-reviewed journals, 23 as first author and 21 as last author. The following are among the most significant:
- Menconi F, Marcocci C, Marinò M. Diagnosis and classification of Graves' disease. Autoimmun Rev. 2014 13:398-402
- Leo M, Marcocci C, Pinchera A, Nardi M, Megna L, Rocchi R, Latrofa F, Altea MA, Mazzi B, Sisti E, Profilo MA, Marinò M. Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial. J Clin Endocrinol Metab. 2012, 97:E44-48
- Botta R, Lisi S, Pinchera A, Giorgi F, Marcocci C, Taddei AR, Fausto AM, Bernardini N, Ippolito C, Mattii L, Persani L, de Filippis T, Calebiro D, Madsen P, Petersen CM, Marinò M. Sortilin is a putative postendocytic receptor of thyroglobulin. Endocrinology. 2009 150: 509-518.
- Marcocci C, Pinchera A, Marino M. A treatment strategy for Graves' orbitopathy. Nat Clin Pract Endocrinol Metab. 2007. 3:430-436.
- Lisi S., Pinchera A., McCluskey R.T., Willnow T.E., Refetoff S., Marcocci C., Vitti P., Menconi F., Grasso L., Luchetti F., Collins A.B., Marinò M. Preferential Megalin-Mediated Transcytosis Of Low Hormonogenic Thyroglobulin: A Novel Control Mechanism For Thyroid Hormone Release. Proc. Natl. Acad. Sci. USA. 2003. 100: 14858-14863.
Contacts
Would you like to book a private visit with Prof. Michele Marinò?
If you would like a (paid) visit, click the button below: